Contraception Sample Clauses

Contraception. Food and Drug Administration-approved contraceptive methods, sterilization procedures, and patient education and counseling;
Sample 1Sample 2Sample 3See All (10)
AutoNDA by SimpleDocs
Contraception. 6.12.1 The Service Provider is required to offer remote assessment and prescribing of contraception and arrange for the dispensing and supply of medication as described in this specification. Medication can be supplied via the post or for collection from a pharmacy. Customers can choose to purchase this component of service and it will therefore not be available to all Service Users. If this is not available, the Service Provider will signpost to other providers of contraception in that area (noting that this could include other e-services).
Sample 1Sample 2Sample 3See All (4)
Contraception. The Proposer is using the following methods of contraception on an ongoing basis: . The Proposer will use the following methods of contraception and/or protection during vaginal/anal* penetrative activities: .The Consenter is using the following methods of contraception on an ongoing basis: .The Consenter will use the following methods of contraception and/or protection during vaginal/anal* penetrative activities: .
Sample 1
Contraception. Study therapy may have adverse effects on a fetus in utero. It is not known if pembrolizumab has transient adverse effects on the composition of sperm. Female patients of reproductive potential must agree to use (or have their partner use) acceptable contraception during heterosexual activity to avoid becoming pregnant or impregnating a partner, respectively, while receiving study drug and for 120 days after the last dose of study drug. See Appendix B for acceptable methods of contraception. For this trial, male partners of female patients of child bearing potential will be considered to be of non-reproductive potential if they have azoospermia (whether due to having had a vasectomy or due to an underlying medical condition). Female patients will be considered of non-reproductive potential if they are either: • postmenopausal (defined as at least 12 months with no menses without an alternative medical cause; in women < 45 years of age a high follicle stimulating hormone (FSH) level in the postmenopausal range may be used to confirm a post-menopausal state in women not using hormonal contraception or hormonal replacement therapy. In the absence of 12 months of amenorrhea, a single FSH measurement is insufficient.); or • have had a hysterectomy and/or bilateral oophorectomy, bilateral salpingectomy or bilateral tubal ligation/occlusion, at least 6 weeks prior to screening; or • has a congenital or acquired condition that prevents childbearing.
Sample 1Sample 2
Contraception. The Proposer is using the following methods of contraception on an ongoing basis:
Sample 1
Contraception. This study found that men presented themselves as authority figures within sexual partnerships responsible for autocratic (individual), consultative (involved), and collaborative (shared) decision-making regarding fertility behavior and consequently couples’ uptake of family planning. Women presented men as primarily autocratic and sometimes consultative decision-makers about childbearing matters, suggesting that men either make decisions independently or involve their partners, but ultimately make final decisions themselves. Shared decision-making did not seem to be a reality for women. Thanks to a growing body of evidence that men’s and women’s fertility desires often differ, researchers have explored questions around the comparative influence of each partner’s fertility preferences relative to the other. This study’s findings are consistent with those of a study in Kenya, which found that contraceptive uptake was two to three times more likely when husbands rather than wives desired to stop childbearing (Blanc, 2001). Another study in Nigeria found that the husband’s desire for additional children dominated when the number of living children was small, but that the effect of the wife’s desire became greater as the number of living children increased (Blanc, 2001). Future research should explore whether HIV modifies this effect. Family planning interventions could target partners by gender based on a couple’s number of existing children. Because preventing HIV-positive pregnancy is one of the four components of comprehensive PMTCT programs, the ability to control pregnancy is critical for preventing pediatric HIV infections. Most women addressed their lack of control over open fertility decision- making within sexual partnerships by practicing surreptitious fertility decision- making (i.e., covertly practicing family planning with non-visible methods such as intra-uterine devices). Women were able to access family planning in secret thanks to the integration of antenatal care and family planning programs; they either pretended to take their existing children for antenatal services or sought contraception during their children’s actual appointments. However, women expressed concern that they learned about family planning too late (i.e., after getting pregnant and presenting to the antenatal clinic) because there were no spaces for family planning education for childless couples. The practice of covert female- controlled contraception use is well documente...
Sample 1
Contraception. The Proposer is using the following methods of contraception on an ongoing basis: _____________________________________________________________________. The Proposer will use the following methods of contraception and/or protection during vaginal/anal* penetrative activities:
Sample 1
AutoNDA by SimpleDocs
Contraception. All women of child bearing potential must have a negative pregnancy test performed at screening and at regular intervals throughout the study.
Sample 1
Contraception. Another factor which also does not have scientific agreement is the association between different contraception techniques and disease progression. One study found that implant contraception and injectables were protective of disease progression, while oral contraception was not (Xxxx et al., 2016). A systematic review agrees with the previous study that injectables were associated with protection of disease progression and oral contraception was not associated (Xxxxxxxx, Xxxxx, & Xxxxxx, 2016). This is contrary to another study which did not find an association between hormonal contraceptives (oral, IUDs, and DMPA) and disease progression among women who were not currently on ART (Xxxxxxxx et al., 2016).
Sample 1

Related to Contraception

  • Subcontracting 6.1 The Grantee is responsible for the performance of its obligations under this Agreement, including in relation to any tasks undertaken by subcontractors.

  • Product ACCEPTANCE Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User(s) shall have thirty (30) days from the date of delivery to accept hardware products and sixty (60) days from the date of delivery to accept all other Product. Where the Contractor is responsible for installation, acceptance shall be from completion of installation. Failure to provide notice of acceptance or rejection or a deficiency statement to the Contractor by the end of the period provided for under this clause constitutes acceptance by the Authorized User(s) as of the expiration of that period. The License Term shall be extended by the time periods allowed for trial use, testing and acceptance unless the Commissioner or Authorized User agrees to accept the Product at completion of trial use. Unless otherwise provided by mutual agreement of the Authorized User and the Contractor, Authorized User shall have the option to run testing on the Product prior to acceptance, such tests and data sets to be specified by User. Where using its own data or tests, Authorized User must have the tests or representative set of data available upon delivery. This demonstration will take the form of a documented installation test, capable of observation by the Authorized User, and shall be made part of the Contractor’s standard documentation. The test data shall remain accessible to the Authorized User after completion of the test. In the event that the documented installation test cannot be completed successfully within the specified acceptance period, and the Contractor or Product is responsible for the delay, Authorized User shall have the option to cancel the order in whole or in part, or to extend the testing period for an additional thirty (30) day increment. Authorized User shall notify Contractor of acceptance upon successful completion of the documented installation test. Such cancellation shall not give rise to any cause of action against the Authorized User for damages, loss of profits, expenses, or other remuneration of any kind. If the Authorized User elects to provide a deficiency statement specifying how the Product fails to meet the specifications within the testing period, Contractor shall have thirty (30) days to correct the deficiency, and the Authorized User shall have an additional sixty (60) days to evaluate the Product as provided herein. If the Product does not meet the specifications at the end of the extended testing period, Authorized User, upon prior written notice to Contractor, may then reject the Product and return all defective Product to Contractor, and Contractor shall refund any monies paid by the Authorized User to Contractor therefor. Costs and liabilities associated with a failure of the Product to perform in accordance with the functionality tests or product specifications during the acceptance period shall be borne fully by Contractor to the extent that said costs or liabilities shall not have been caused by negligent or willful acts or omissions of the Authorized User’s agents or employees. Said costs shall be limited to the amounts set forth in the Limitation of Liability Clause for any liability for costs incurred at the direction or recommendation of Contractor.

  • Validation To validate the notice requirements outlined in Section 5.3, the Assuming Institution shall provide the Receiver (i) an Affidavit of Publication to meet the publication requirements outlined in Section 5.3(a) and (ii) the Assuming Institution will prepare an Affidavit of Mailing in a form substantially similar to Exhibit 2.3B after mailing the seven (7) day Notice to Depositors as required under Section 5.3(b).

  • Subcontractor Any vendor, subcontractor or other Person that is not responsible for the overall servicing (as “servicing” is commonly understood by participants in the mortgage-backed securities market) of Mortgage Loans but performs one or more discrete functions identified in Item 1122(d) of Regulation AB with respect to Mortgage Loans under the direction or authority of the Servicer or a Subservicer.

  • Sub-Contracting 31.1. The Authority approves the appointment of the sub-contractors specified in Schedule 10 (Approved Sub-contractors) in respect of the obligations specified in that Schedule.

Time is Money Join Law Insider Premium to draft better contracts faster.